Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (121-130 of 536) with videos related to

Pageof 54
Sort By:
Blood|November 10, 2009
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsetsJianhua Yu, Hsiaoyin C Mao, Min Wei, et al.
Stem Cell Research & Therapy|April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective studyDat Ngo, Jason Chen, Jose Tinajero, et al.
Molecular Pharmaceutics|August 22, 2007
Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cellsYanhui Lu, Jun Wu, Jianmei Wu, et al.
Cell|January 11, 2024
Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell deathZhenlong Li, Rui Ma, Hejun Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse modelSukhinder K Sandhu, Stefano Volinia, Stefan Costinean, et al.
Leukemia Research|September 9, 2011
High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemiaAndrea Kühnl, Martin Kaiser, Martin Neumann, et al.
Nature Immunology|June 15, 2022
Publisher Correction: ILC1s control leukemia stem cell fate and limit development of AMLZhenlong Li, Rui Ma, Shoubao Ma, et al.
Nature Immunology|April 29, 2022
ILC1s control leukemia stem cell fate and limit development of AMLZhenlong Li, Rui Ma, Shoubao Ma, et al.
Blood|July 12, 2008
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type alleleAdrienne M Dorrance, Shujun Liu, Anita Chong, et al.
Blood|February 17, 2012
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETOFu-Sheng Chou, Andrea Griesinger, Mark Wunderlich, et al.
Pageof 54

Showing results (121-130 of 536) with videos related to

Sort By:
Pageof 54
Blood|November 10, 2009
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsetsJianhua Yu, Hsiaoyin C Mao, Min Wei, et al.
Stem Cell Research & Therapy|April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective studyDat Ngo, Jason Chen, Jose Tinajero, et al.
Molecular Pharmaceutics|August 22, 2007
Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cellsYanhui Lu, Jun Wu, Jianmei Wu, et al.
Cell|January 11, 2024
Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell deathZhenlong Li, Rui Ma, Hejun Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse modelSukhinder K Sandhu, Stefano Volinia, Stefan Costinean, et al.
Leukemia Research|September 9, 2011
High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemiaAndrea Kühnl, Martin Kaiser, Martin Neumann, et al.
Nature Immunology|June 15, 2022
Publisher Correction: ILC1s control leukemia stem cell fate and limit development of AMLZhenlong Li, Rui Ma, Shoubao Ma, et al.
Nature Immunology|April 29, 2022
ILC1s control leukemia stem cell fate and limit development of AMLZhenlong Li, Rui Ma, Shoubao Ma, et al.
Blood|July 12, 2008
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type alleleAdrienne M Dorrance, Shujun Liu, Anita Chong, et al.
Blood|February 17, 2012
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETOFu-Sheng Chou, Andrea Griesinger, Mark Wunderlich, et al.
Pageof 54